@FiercePharma: Top-read in #pharma #manufacturing Tues: Dr. Reddy's, Endo benefit from Ranbaxy manufacturing shortfalls. More | Follow @FiercePharma
@EricPFierce: Cadilia gets slapped with #FDA warning for not following up on complaints about stinking APIs. More | Follow @EricPFierce
@CarlyHFierce: Mylan visits Disney Parks for a little EpiPen marketing magic. More | Follow @CarlyHFierce
> India's Aurobindo Pharma won a bankruptcy auction to buy the California-based nutritional supplements company Natrol for $132.5 million. Report
> After Scotland's cost-effectiveness watchdogs refused to approve Roche's ($RHHBY) new breast cancer drug Perjeta, patient groups started agitating for a price cut. Report
> Pfizer ($PFE) launched an authorization system for its products in Malaysia, to help patients separate authentic products from counterfeits. Report
Medical Device News
@FierceMedDev: ICYMI yesterday: With fresh infusion of cash in tow, Thync rolls out wearable, noninvasive device to elevate mood. Article | Follow @FierceMedDev
@VarunSaxena2: Aethlon to begin U.S. testing for its Ebola treatment device by year end. More | Follow @VarunSaxena2
@EmilyWFierce: Mark your calendars: EU Commission will decide by Nov. 28 whether or not to approve $MDT's $43B deal for $COV. More | Follow @EmilyWFierce
> Medtronic borrows $16B to cover rising costs of Covidien deal. Article
> FDA clears first patient-specific spinal rod. More
Biotech News
@FierceBiotech: $AMGN and $AZN psoriasis drug beats blockbuster Stelara ($JNJ) in head-to-head trial. Report | Follow @FierceBiotech
@JohnCFierce: Servier gambling up to $1B-plus on Intarcia's PhIII diabetes drug/device. News | Follow @JohnCFierce
@DamianFierce: Hep C market share optimism has $ABBV up. Also, cab ads. Picture | Follow @DamianFierce
> Takeda's Millennium re-ups with Presage on cancer drug combo effort. Item
> Blueprint Medicines banks $50M for its personalized take on cancer. News
> Fujifilm says its flu drug is an Ebola solution in waiting. Article
Drug Delivery News
> Drug-loaded milk could offer oral HIV/AIDS prevention to children. Story
> Alnylam adds two RNAi programs to its hepatitis pipeline. Article
> Arrowhead's midstage hep B data shows promise for RNA-based 'functional cure.' News
> FDA clears syringe that prevents needlestick injuries. News
> Nasal spray for migraines under development. Story
Diagnostics News
> Study: Myriad skin cancer Dx shows reduction in indeterminate diagnoses. More
> GE Healthcare lends imaging tech to Takeda for Dx partnership. Story
> Quest CEO says 'no' to CRO. Report
> Study: Myriad skin cancer Dx shows reduction in indeterminate diagnoses. More
> GE Healthcare lends imaging tech to Takeda for Dx partnership. Item
> Scientists developing machine-based algorithm for heart failure and emphysema Dx. Article
Pharma Marketing News
> Under siege by Biogen's new long-acting Eloctate, Baxter's Advate stands its ground. Report
> Missing the old pharma swag? Take a trip down memory lane. Article
> Will GLP market growth save Novo's Victoza from Lilly's new Trulicity? More
> Contrave demand swamps Takeda's direct-delivery discount program. Story
> Mylan visits Disney Parks for a little EpiPen marketing magic. Article
And Finally... Former Apple ($AAPL) CEO John Sculley grabbed a stake in the telemedicine company MDLive, saying he sees online services "going mainstream" in coming years. Report